Asia Pacific Anatomic Pathology Market Size & Outlook

The anatomic pathology market in Asia Pacific is expected to reach a projected revenue of US$ 24,682.3 million by 2033. A compound annual growth rate of 12.4% is expected of Asia Pacific anatomic pathology market from 2026 to 2033.
Revenue, 2025 (US$M)
$9,492.4
Forecast, 2033 (US$M)
$24,682.3
CAGR, 2026 - 2033
12.4%
Report Coverage
Asia Pacific

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific anatomic pathology market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific anatomic pathology market highlights

  • The Asia Pacific anatomic pathology market generated a revenue of USD 9,492.4 million in 2025.
  • The market is expected to grow at a CAGR of 12.4% from 2026 to 2033.
  • In terms of segment, consumables was the largest revenue generating product & services in 2025.
  • Instruments is the most lucrative product & services segment registering the fastest growth during the forecast period.
  • Country-wise, China is expected to register the highest CAGR from 2026 to 2033.


Asia Pacific data book summary

Market revenue in 2025USD 9,492.4 million
Market revenue in 2033USD 24,682.3 million
Growth rate12.4% (CAGR from 2026 to 2033)
Largest segmentConsumables
Fastest growing segmentInstruments
Historical data covered2021 - 2024
Base year for estimation2025
Forecast period covered2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationServices, Instruments, Consumables
Key market players worldwideDanaher Corp, PHC Holdings Corp, Quest Diagnostics Inc, Labcorp Holdings Inc, Roche Holding AG ADR, Agilent Technologies Inc, Cardinal Health Inc, Sakura Finetek USA, Inc., NeoGenomics, Biogenex, Bio SB


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 24.8% of the global anatomic pathology market in 2025.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 24,682.3 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Anatomic Pathology Market Companies

Name Profile # Employees HQ Website
Bio SB View profile 11-50 Goleta, California, United States, North America https://www.biosb.com/
Biogenex View profile 51-100 Fremont, California, United States, North America https://biogenex.com
NeoGenomics View profile 501-1000 Fort Myers, Florida, United States, North America http://www.neogenomics.com
Sakura Finetek USA, Inc. View profile 101-250 Torrance, California, United States, North America http://sakuraus.com
PHC Holdings Corp View profile 11897 2-38-5 Nishi-Shimbashi, Minato-ku, Tokyo, Japan, 105-8433 https://www.phchd.com
Labcorp Holdings Inc View profile 67000 358 South Main Street, Burlington, NC, United States, 27215 https://www.labcorp.com
Cardinal Health Inc View profile 48000 7000 Cardinal Place, Dublin, OH, United States, 43017 https://www.cardinalhealth.com
Agilent Technologies Inc View profile 17700 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 https://www.agilent.com
Quest Diagnostics Inc View profile 48000 500 Plaza Drive, Secaucus, NJ, United States, 07094 https://www.questdiagnostics.com
Danaher Corp View profile 63000 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 https://www.danaher.com
Roche Holding AG ADR View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com

Asia Pacific anatomic pathology market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anatomic pathology market will help companies and investors design strategic landscapes.


Consumables was the largest segment with a revenue share of 78.58% in 2025. Horizon Databook has segmented the Asia Pacific anatomic pathology market based on services, instruments, consumables covering the revenue growth of each sub-segment from 2021 to 2033.


With two-thirds of the world’s population, improving economies in this region as well as growing demand for testing in this region is expected to boost market growth over the forecast period.

Use of biomarkers in anatomic pathology practices in this region is different from western markets as this regional market is primarily based on lower labor costs, high population, and low-cost operations.

Reasons to subscribe to Asia Pacific anatomic pathology market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific anatomic pathology market databook

  • Our clientele includes a mix of anatomic pathology market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific anatomic pathology market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific anatomic pathology market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific anatomic pathology market size, by country, 2021-2033 (US$M)

Asia Pacific Anatomic Pathology Market Outlook Share, 2025 & 2033 (US$M)

Asia Pacific anatomic pathology market size, by country, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online